Navigation Links
The Show Goes on for Pulmonary Fibrosis Patient Jerry Lewis
Date:9/4/2009

His Longevity with the Deadly Disease Inspires Thousands of Dying Patients

SAN JOSE, Calif., Sept. 4 /PRNewswire-USNewswire/ -- When Jerry Lewis takes the stage again on Labor Day 2009 for the Muscular Dystrophy Association Telethon, thousands of people who suffer from the same lung disease as he will be watching - and not just to hear the funny things he'll say. They'll be looking for inspiration from the funny man who suffers from a not-so-funny and little known fatal lung disease.

Lewis disclosed several years ago that he is dying from Pulmonary Fibrosis (PF), a disease that suffocates its victims by scarring the lungs. The disease is irreversible, untreatable, and invariably fatal. Most patients die within three years of diagnosis, which is why many are looking to the celebrity for clues to his survival for so many years with the disease. They are also looking to him to speak out about PF, a disease that is barely known by much of the public and is in desperate need of increased research funding to find ways to successfully treat it.

"I have to say, I'm curious," said patient Ellen Foley. "There is no FDA-approved treatment for this disease and many of us are going downhill very quickly. He doesn't seem to be and I'm really happy for him. As for me, I'm on supplemental oxygen 24 hours a day."

Lewis has spoken many times publicly about his disease but has not yet spoken out on behalf of the cause that has stricken him so personally. The Coalition for Pulmonary Fibrosis (CPF) would ask Lewis to help give a voice to hundreds of thousands of people who are and will soon be affected by PF. "A celebrity voice could change the future for thousands of patients by bringing much-needed attention to the cause," said Mishka Michon, the Chief Executive Officer for the CPF. "So many celebrities haven't lived long enough with the disease to make their voices heard before they died, like Robert Goulet, Marlon Brando and Odetta. We would be so appreciative if Mr. Lewis would help us."

One of the biggest problems the CPF faces is getting the attention of the public, including the media, on PF. No major national media coverage to date has been known to focus on the disease that threatens the lives of all Americans and claims 40,000 lives a year - the same number as breast cancer. "Everyone is at risk for the disease," said Marvin Schwarz, M.D., top PF pulmonologist and researcher from the University of Colorado Denver and Chairman of the CPF board of directors. "We don't know what causes it, we don't know how to stop it and we don't know what to do to prevent it. Much more research is needed to find the answers we've been seeking for years and so urgently need now."

About Pulmonary Fibrosis (PF)

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thirds of patients die within five years of diagnosis. Sometimes PF can be linked to a particular cause, such as certain environmental exposures, chemotherapy or radiation therapy, residual infection, or autoimmune diseases such as scleroderma or rheumatoid arthritis. However, in many instances, no known cause can be established. When this is the case, it is called idiopathic pulmonary fibrosis (IPF).

About the CPF

The CPF is a 501(c)(3) nonprofit organization, founded in 2001 to accelerate research efforts leading to a cure for pulmonary fibrosis (PF), while educating, supporting, and advocating for the community of patients, families, and medical professionals fighting this disease. The CPF funds promising research into new approaches to treat and cure PF; provides patients and families with comprehensive education materials, resources, and hope; serves as a voice for national advocacy of PF issues; and works to improve awareness of PF in the medical community as well as the general public. The CPF's nonprofit partners include many of the most respected medical centers and healthcare organizations in the U.S. With more than 19,000 members nationwide, the CPF is the largest nonprofit organization in the U.S. dedicated to advocating for those with PF. For more information please visit www.coalitionforpf.org or call (888) 222-8541.


'/>"/>
SOURCE Coalition for Pulmonary Fibrosis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AUDIO from Medialink, Boehringer Ingelheim Pharmaceuticals, Inc. & Pfizer Inc.: Coping with Chronic Obstructive Pulmonary Disease (COPD)
2. U-M researchers discover therapeutic target that could help patients with pulmonary fibrosis
3. Pulmonary CT angiography identifies disease and injury beyond the pulmonary arteries in children
4. FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension
5. NHLBI stops study of pulmonary hypertension treatment in sickle cell patients
6. CPF Announces Dates for Seventh Annual National Pulmonary Fibrosis Awareness Week
7. An Increase in the Diagnosed Prevalent Population Will Drive Growth of Nearly $4.3 Billion in the Chronic Obstructive Pulmonary Disease Market
8. Scienceroll.com on an iPhone Application for Cardiopulmonary Resuscitation Training
9. New Source of Information on Pulmonary Hypertension Medications
10. CPF, Pulmonary Fibrosis Experts Guests on Sirius and XM Satellite Radio Show June 16th
11. New Shape-HF™ Cardiopulmonary Testing System to be on Display at 2009 American Association of Heart Failure Nurses Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may ... to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To ... for healthy coping following a traumatic event. , Trauma sufferers tend to feel a ...
(Date:6/24/2016)... ... 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out of ... verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... throw rocks at my other children and say he was going to kill them. ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... MEMS Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data ... analysis. Assessment of major trends with potential impact on the ... analysis of market segmentation which comprises of sub markets, regional ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... June 23, 2016  Guerbet announced today that it ... Supplier Horizon Award . One of 12 ... recognized for its support of Premier members through exceptional ... excellence, and commitment to lower costs. ... recognition of our outstanding customer service from Premier," says ...
Breaking Medicine Technology: